U.S. Risks Losing Highly Skilled Immigrants
... of ocean uses that takes into account the cumulative effects of multiple human activities. Closing the Environmental Data Gap . Robin O'Malley, anne Marsh, and Christine Negra of the Heinz Center in Washington, DC, write that information limitations are severely constraining our ability to identify...Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia
...proved drug therapy. Enzyme Replacement Therapy for the treatment of hypophosphatasia is the Company's lead program. Enobia Contact: Julie anne Smith, (514) 596-2901, extension 214 ...Syngenta Enters Into Research Collaboration With Anhui Academy, China
..., or be relied on in connection with, any contract therefor. Media contacts: Medard Schoenmaeckers Switzerland +41 61 323 2323 anne Burt USA +1 202 628 2372 Analyst/Investor contacts: Jennifer Gough Switzerland +41 61 323 5059 USA +1 202 737 6521 John Hud...Accidental discovery has potential for new applications in packaging
... "This work takes a step toward developing more flexible, optically transparent, ultra-high barrier polymers for several different applications," said anne Hiltner, lead author of the study and the Herbert Henry Dow Professor of Science and Engineering at Case Western Reserve. She also serves as lead inve...AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System)
...s clear advantages in the service we can provide to our clients," said anne Wiles, senior VP, data systems and process, AAIPharma. ...s clear advantages in the service we can provide to our clients," said anne Wiles, Senior Vice President, Data Systems and Process, AAIPharma. &quo...23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
... Genome Service(TM) enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its ...Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial
... for the treatment of autoimmune diseases from Amgen. For more information, please visit www.anthera.com . INVESTOR AND MEDIA CONTACT: anne Bowdidge (650) 218-6900 pr@anthera.com ...GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
...tephen Rea (020) 8047 5502 US Media enquiries: Nancy Pekarek (919) 483 2839 Mary anne Rhyne (919) 483 2839 Sarah Alspach (215) 751 7709 Melinda Stubbe...New research field promises radical advances in optical technologies
... 17) in the journal Science . The article will appear in the magazine's Perspectives section and was written by Vladimir Shalaev, Purdue's Robert and anne Burnett Professor of Electrical and Computer Engineering. The list of possible breakthroughs includes a cloak of invisibility; computers and consum...Connecticut's Universities Team Up to Host 2009 Stem Cell Symposium
... Temple Ph.D., Albany Medical Center. -- A session on bioethics organized by Lori Gruen Ph.D., of Wesleyan University in collaboration with anne Hiskes Ph.D., of the University of Connecticut. -- A session on "Translation to Clinic" that will look at the opportunities and barriers t...23andMe Announces Breast Cancer Initiative
...tober as National Breast Cancer Awareness Month, co-founders Linda Avey and anne Wojcicki told science and business leaders at Fortune's Most Powerful Women...ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and anne Wojcicki in 2006, and the company is advised by a group of renowned experts...Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
...ares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor. Media contacts: anne Burt 202 628 2372 ...No Blood Needed Thanks to Innovative Medical Technology
...l-7 includes a unique technology platform that allows for additional features to be added as simple software upgrades. In congratulating the winner, anne Trimmer, MTAA CEO, said: "Masimo's Oximeter is an excellent example of innovation in the medical technology sector. It benefits the patient, the clini...GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
... Gwenan White +44(0)20-8047-5502 US Media enquiries Nancy Pekarek +1-215-751-7709 Mary anne Rhyne +1-919-483-2839 Sarah Alspach +1-215-751-7709 European Analyst/Investor David Mawdsley +44...Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
...t; John M. Vuko, executive vice president and chief financial officer; Beth anne Piper, M.D., vice president, clinical development; and Stephen Worsley, vic... a public company, which raised over $600 million during his tenure. Beth anne Piper, M.D., vice president, clinical development brings 19 years of clinic...Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
..., for the treatment of autoimmune diseases from Amgen. For more information, please visit http://www.anthera.com . INVESTOR AND MEDIA CONTACT: anne Bowdidge (650) 218-6900 pr@anthera.com ...IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea
...etes.org/diabetes-statistics/cost-of-diabetes-in-us.jsp [5] Diabet es Atlas, third edition. International Diabetes Federation, 2006 Contacts: anne Pierson, IDF Office: +32-2-5431623 Mobile: +32-475-343788 Email:media@idf.org Kerrita McClaughlyn, IDF Office: +32-2-5431639 Mobile: +32-487-53...Amarin Announces Financial Results for Fourth Quarter and Full Year 2007
... Cunningham, EVP Strategic Development and Investor Relations investor.relations@amarincorp.com Investors: Lippert/Heilshorn & Associates, Inc. anne Marie Fields +1-212-838-3777 Bruce Voss +1-310-691-7100 Media: Powerscourt +44(0)207-250-1446 Rory Godson Paul Durman ...iCAD Reports First Quarter 2008 Financial Results
...ene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com For iCAD Investor Relations, contact anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at afields@lhai.com For iCAD Public Relations, contact Jill Te...Anthera Presents Data on Varespladib at ATVB Meeting
...matosus (SLE) and other autoimmune diseases from Amgen. For more information, please visit http://www.anthera.com INVESTOR AND MEDIA CONTACT: anne Bowdidge (650) 218-6900 pr@anthera.com ...Evotec Announces Financial Results for 2007
...07,878 243,123 (14) *Excluding early payments received for Evotec Technologies. **Including assets held for sale. Contact: Evotec AG anne Hennecke SVP, Investor Relations & Corporate Communications Phone: +49(0)40-56081-286 Fax: +49(0)40-56081-333 E-Mail: anne.hennecke@evotec.com ...Varian Medical Systems Schedules Second Quarter FY2008 News Release and Conference Call
...rested parties at 2:00 p.m. PT. The Varian Medical Systems quarterly results can be accessed on April 23, 2008 via: News Release: Contact anne Rambo via phone at 650-424-5834 or via e-mail at anne.rambo@varian.com to have a copy of the news release ...Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet
...4272 The on-demand version of the webcast will be available on our website: http://www.evotec.com - Investors - Webcasts. Contact: Evotec AG anne Hennecke SVP, Investor Relations & Corporate Communications Phone: +49-40-56081-286 Fax: +49-40-56081-333 E-Mail: anne.hennecke@evotec.com ...Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
...bsite at http://www.evotec.com - Investors. A replay will be available at http://www.evotec.com - Investors - Webcasts. Contact: Evotec AG, anne Hennecke, SVP, Investor Relations & Corporate Communications, Phone: +49(0)40-56081-286, Fax: +49(0)40-56081-333, E-Mail: anne.hennecke@evotec.co...iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
...r iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com For iCAD Investor Relations, contact anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at icad@lhai.com For iCAD Public Relations, contact Wendy Ryan of ...Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
...ange in the parties' expectations or any change in events, conditions or circumstances on which any such statement is based. Contact: Evotec AG anne Hennecke SVP, Investor Relations & Corporate Communications Phone: +49(0)40-56081-286 Fax: +49(0)40-56081-333 E-Mail: anne.hennecke@evotec.com ...iCAD to Feature New Products and Capabilities at European Congress of Radiology
...r iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com For iCAD Investor Relations, contact anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at icad@lhai.com For iCAD Public Relations, contact Wendy Ryan of ...Evotec Expands Collaboration With InterMune
...nge in the parties' expectations or any change in events, conditions or circumstances on which any such statement is based. Contact: Evotec AG anne Hennecke SVP, Investor Relations & Corporate Communications Phone: +49(0)40-56081-286 Fax: +49(0)40-56081-333 E-Mail: anne.hennecke@evotec.com ...Filing of 2007 Annual Report on Form 20-F
...nformation is available at http://www.syngenta.com . Media Enquiries: Medard Schoenmaeckers (Switzerland) +41 61 323 2323 anne Burt (US) +1 202 628 2372 Analysts/Investors: Jonathan Seabrook +41 61 323 7502 ...